MARKET NEWS

Catalent Completes Acquisition of Gene Therapy Leader for $1.2 Billion
CureVac Enters Into Exclusive Sponsored Research Agreement
Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner
Saama Challenges Analytics Industry to Guarantee Data Platforms to Help Accelerate Drug Development
Owlstone Medical Enters Strategic Collaboration With Actelion
Crinetics Pharmaceuticals Initiates Phase 1 Study for Treatment of Neuroendocrine Tumors

  FEATURED EDITORIAL

  COMPANY PROFILE

Drug Delivery Experts (DDE Labs) is a contract R&D drug delivery laboratory located in San Diego’s emerging biotech sector that specializes in drug product development. We have the expertise to integrate drug delivery formulations with the appropriate device to maximize commercial potential. DDE Labs was created in 2014 to address the gap of good outsourcing partners in the formulation and drug delivery technology landscape. We specialize in drug-device combination product development and integration of formulation and delivery system approaches with commercial strategy and life-cycle plans. We work in the injectable products space as well as alternate delivery systems. Click here for more.

  EXCLUSIVE ONLINE CONTENT

WuXi STA & Dizal Pharmaceutical Sign Agreement

WuXi STA & Dizal Pharmaceutical Sign Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, recently announced a strategic partnership.

Mercia Invests in Transdermal Drug Delivery Specialist

Mercia Invests in Transdermal Drug Delivery Specialist

Medherant Limited, the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch technology, recently announced a new $2.5-million investment.

Catalent to Launch OneBio Suite for Integrated Biologics Development, Manufacturing & Supply

Catalent to Launch OneBio Suite for Integrated Biologics Development, Manufacturing & Supply

Catalent (Booth 3101) recently announced it will launch its new OneBio Suite for the integrated development, manufacturing, and clinical supply of biologic drugs at the BIO International Convention, which takes place at the Pennsylvania Convention Center in Philadelphia, from June 3-6, 2019.

OneBio has been designed specifically to address the challenges facing biologic development companies that are looking to accelerate programs to clinic or market, or that require greater simplicity in the development process,

 » Read more about: Catalent to Launch OneBio Suite for Integrated Biologics Development, Manufacturing & Supply  »

Bayer Launches PHAB Awards With up to  Million in Grants 

Bayer Launches PHAB Awards With up to $1 Million in Grants 

Bayer U.S recently announced the launch of the PHAB Awards to support clinical research in pulmonary hypertension, with a focus on pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

June 5 – Capsules
June 12 – Injection Devices